olmesartan has been researched along with Duodenal Diseases in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Genta, RM; Green, PHR; Lebwohl, B; Uche-Anya, EN | 1 |
Albeldawi, M; Gaur, V; Weber, L | 1 |
Khan, AS; Peter, S; Wilcox, CM | 1 |
Biagi, F; Corazza, GR; Cumetti, D; Luinetti, O; Mugellini, A; Schiepatti, A; Sonzogni, A | 1 |
Capone, P; Caporaso, N; Imperatore, N; Rispo, A; Tortora, R | 1 |
6 other study(ies) available for olmesartan and Duodenal Diseases
Article | Year |
---|---|
Regional Patterns of Olmesartan Prescription and the Prevalence of Duodenal Villous Atrophy Throughout the United States.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Duodenal Diseases; Female; Humans; Imidazoles; Male; Microvilli; Middle Aged; Prescriptions; Prevalence; Tetrazoles; United States; Young Adult | 2018 |
In brief: Olmesartan and sprue-like enteropathy.
Topics: Angiotensin II Type 1 Receptor Blockers; Diarrhea; Duodenal Diseases; Humans; Imidazoles; Malabsorption Syndromes; Risk Factors; Tetrazoles; Weight Loss | 2018 |
Chronic diarrhea and weight loss.
Topics: Antihypertensive Agents; Chronic Disease; Diarrhea; Duodenal Diseases; Humans; Imidazoles; Male; Middle Aged; Tetrazoles; Weight Loss | 2014 |
Olmesartan-induced enteropathy resembling celiac disease.
Topics: Aged; Antihypertensive Agents; Atrophy; Capsule Endoscopy; Celiac Disease; Diagnostic Errors; Duodenal Diseases; Female; Humans; Ileitis; Imidazoles; Intestinal Mucosa; Jejunal Diseases; Tetrazoles | 2014 |
Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases.
Topics: Aged; Antihypertensive Agents; Atrophy; Duodenal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Tetrazoles | 2016 |
An emerging issue in differential diagnosis of diarrhea: sprue-like enteropathy associated with olmesartan.
Topics: Antihypertensive Agents; Atrophy; Celiac Disease; Diagnosis, Differential; Diarrhea; Duodenal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Tetrazoles | 2016 |